Výsledky vyhledávání - "Hana Althobaiti"

Akademický článek

Impact of an Advanced Practice Pharmacist Type 2 Diabetes Management Program: A Pilot Study

Autor: Jelena Lewis, Tiffany Nguyen, Hana Althobaiti, Mona Alsheikh, Brad Borsari, Suzanne Cooper, David Kim, Enrique Seoane-Vazquez

Publikováno v: INNOVATIONS in Pharmacy, Vol 10, Iss 4 (2019)

Background: The purpose of this study was to describe the impact of an Advanced Practice Pharmacist (APh) on lowering hemoglobin A1c (HbA1c) in patients with type 2 diabetes within a patient centered medical home (PCMH) and to classify the types of t

Externí odkaz: https://doaj.org/article/270f5cd1feb444e2ac42adb6e462a89f

Zobrazit plný text záznamu

Disentangling the Cost of Orphan Drugs Marketed in the United States

Autor: Hana Althobaiti, Enrique Seoane-Vazquez, Lawrence M. Brown, Marc L. Fleming, Rosa Rodriguez-Monguio

Publikováno v: Healthcare
Volume 11
Issue 4
Pages: 558

The increasing number and high prices of orphan drugs have triggered concern among patients, payers, and policymakers about the affordability of new drugs approved using the incentives set by the Orphan Drug Act (ODA) of 1983. This study evaluated th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f9cc893de744af7a9954e1f21c6edcf

Zobrazit plný text záznamu

FDA Orphan Designations, Approvals, and Regulatory Review Time since the Enactment of the Orphan Drug Act (1983)

Autor: Hana Althobaiti, Enrique Seoane-Vazquez, Lawrence M Brown, Marc L. Fleming, Rosa Rodriguez-Monguio

Background Drug approvals for rare diseases and conditions have increased significantly since the Orphan Drug Act (ODA) enactment in 1983. Yet, the factors explaining the increase in orphan drug approvals are poorly understood. This study assessed th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::89164deffd5310ac9bc348e4e100aa81
https://doi.org/10.21203/rs.3.rs-1919358/v1